Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen

Clinical trial NCT05731258 · RECRUITING

Trial details

NCT number: NCT05731258
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Liposomal Doxorubicin Efficacy Safety Postoperative Adjuvant Treatment

Start date: 2022-05-01
Primary completion: 2027-10-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.